# Trimetazidine Therapy in Hypertrophic Cardiomyopathy

> **NCT01696370** · PHASE2 · UNKNOWN · sponsor: **University College, London** · enrollment: 90 (estimated)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** Trimetazidine
- **OTHER:** Placebo capsule

## Key facts

- **NCT ID:** NCT01696370
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2013-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01696370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01696370, "Trimetazidine Therapy in Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01696370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*